Jessica S. Armer
Research Subjects
Jessica S. Armer has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Susan K. Lutgendorf
Department of Psychological and Brain Sciences University of Iowa Iowa City Iowa USA
3 shared publications Anil K. Sood
Gyneclogic Oncology, Cancer Biology, and Center for RNA Interference and Noncoding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas
1 shared publication- Bonnie A. McGregor
Orion Center for Integrative Medicine, Seattle, Washington
1 shared publication David P. Bender
Gynecologic Oncology, Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa
1 shared publication- Ellen M. Kinner
Department of Psychological & Brain Sciences, University of Iowa, United States
1 shared publication - Frank J. Penedo
University of Miami
1 shared publication
Latest Publications
- Open Access
- 17 December 2019
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 4 (2) , pkz098
The Impact of Yoga on Fatigue in Cancer Survivorship: A Meta-Analysis
Mind-body approaches, particularly yoga, are used by cancer survivors to cope with treatment-related symptoms. Consistency of yoga-related effects on treatment-related symptoms are not known. This meta-analysis was designed to examine effects of yoga on pre- to postintervention improvements in fatigue among cancer patients. PubMed and PsycINFO were searched for peer-reviewed articles of yoga randomized controlled trials including cancer survivors and reporting at least one fatigue measure. Twenty-nine studies met inclusion criteria (n = 1828 patients). Effect sizes (Hedge’s g) were calculated for fatigue, depression, and quality of life. Patient-related and intervention-related characteristics were tested as moderators of outcomes. All statistical tests were two-sided. Yoga practice was associated with a small, statistically significant decrease in fatigue (g = 0.45, P = .013). Yoga type was a statistically significant moderator of this relationship (P = .02). Yoga was associated with a moderate decrease in depression (g = 0.72, P = .007) but was not associated with statistically significant changes in quality of life (P = .48). Session length was a statistically significant moderator of the relationship between yoga and depression (P = .004). Neither timing of treatment (during treatment vs posttreatment) nor clinical characteristics were statistically significant moderators of the effects of yoga on outcomes. The effect of yoga on fatigue and depression was larger when the comparator was a “waitlist” or “usual care” than when the control group was another active treatment (P = .036). Results suggest yoga may be beneficial as a component of treatment for both fatigue and depression in cancer survivors.
- 17 December 2019
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 4 (2) , pkz098
Open AccessThe Impact of Yoga on Fatigue in Cancer Survivorship: A Meta-Analysis
Mind-body approaches, particularly yoga, are used by cancer survivors to cope with treatment-related symptoms. Consistency of yoga-related effects on treatment-related symptoms are not known. This meta-analysis was designed to examine effects of yoga on pre- to postintervention improvements in fatigue among cancer patients. PubMed and PsycINFO were searched for peer-reviewed articles of yoga randomized controlled trials including cancer survivors and reporting at least one fatigue measure. Twenty-nine studies met inclusion criteria (n = 1828 patients). Effect sizes (Hedge’s g) were calculated for fatigue, depression, and quality of life. Patient-related and intervention-related characteristics were tested as moderators of outcomes. All statistical tests were two-sided. Yoga practice was associated with a small, statistically significant decrease in fatigue (g = 0.45, P = .013). Yoga type was a statistically significant moderator of this relationship (P = .02). Yoga was associated with a moderate decrease in depression (g = 0.72, P = .007) but was not associated with statistically significant changes in quality of life (P = .48). Session length was a statistically significant moderator of the relationship between yoga and depression (P = .004). Neither timing of treatment (during treatment vs posttreatment) nor clinical characteristics were statistically significant moderators of the effects of yoga on outcomes. The effect of yoga on fatigue and depression was larger when the comparator was a “waitlist” or “usual care” than when the control group was another active treatment (P = .036). Results suggest yoga may be beneficial as a component of treatment for both fatigue and depression in cancer survivors.
Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer
BACKGROUND: Patients with ovarian cancer often report elevated anxiety at diagnosis that decreases posttreatment. However, a minority of patients experience sustained anxiety. Few studies have examined risk factors for persistent anxiety or its physiologic sequelae in ovarian cancer. Therefore, the authors investigated associations between prior life events, anxiety, inflammation (plasma levels of interleukin‐6), and diurnal cortisol profiles in patients with ovarian cancer during the first year postdiagnosis. METHODS: Participants (n = 337) completed surveys and had blood and salivary sampling prediagnosis, postchemotherapy (6 months), and 12 months after diagnosis. The Life Events and Difficulties Schedule was administered to a patient subset (n = 127) within 1 month of diagnosis. Linear mixed‐effects models were used to analyze relations between anxiety and biologic variables over time. Linear regression models assessed whether anxiety trajectories mediated associations between prior stress exposure and biologic variables. Age, chemotherapy at 1 year, and cancer stage were covariates. RESULTS: Decreased anxiety was associated with a more normalized cortisol slope over time (β = 0.092; P = .047). Early life adversity was related to flatter cortisol slopes over time (β = −0.763; P = .002); this relation was partially mediated by anxiety trajectory ( P = .046). More danger‐related events prediagnosis were associated with sustained anxiety (β = 0.537; P = .019) and flatter cortisol slopes over time (β = −0.243; P = .047); anxiety partially mediated the relation between danger and cortisol slope ( P = .037). Neither anxiety nor prior stress exposure was related to levels of interleukin‐6. CONCLUSIONS: Because dysregulated cortisol has been related to fatigue, poorer quality of life, and shorter survival in patients with ovarian cancer, those who have prior life events and chronic anxiety during the first year postdiagnosis may be at risk for more negative outcomes. Cancer 2018 . © 2018 American Cancer Society .
Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer
BACKGROUND: Patients with ovarian cancer often report elevated anxiety at diagnosis that decreases posttreatment. However, a minority of patients experience sustained anxiety. Few studies have examined risk factors for persistent anxiety or its physiologic sequelae in ovarian cancer. Therefore, the authors investigated associations between prior life events, anxiety, inflammation (plasma levels of interleukin‐6), and diurnal cortisol profiles in patients with ovarian cancer during the first year postdiagnosis. METHODS: Participants (n = 337) completed surveys and had blood and salivary sampling prediagnosis, postchemotherapy (6 months), and 12 months after diagnosis. The Life Events and Difficulties Schedule was administered to a patient subset (n = 127) within 1 month of diagnosis. Linear mixed‐effects models were used to analyze relations between anxiety and biologic variables over time. Linear regression models assessed whether anxiety trajectories mediated associations between prior stress exposure and biologic variables. Age, chemotherapy at 1 year, and cancer stage were covariates. RESULTS: Decreased anxiety was associated with a more normalized cortisol slope over time (β = 0.092; P = .047). Early life adversity was related to flatter cortisol slopes over time (β = −0.763; P = .002); this relation was partially mediated by anxiety trajectory ( P = .046). More danger‐related events prediagnosis were associated with sustained anxiety (β = 0.537; P = .019) and flatter cortisol slopes over time (β = −0.243; P = .047); anxiety partially mediated the relation between danger and cortisol slope ( P = .037). Neither anxiety nor prior stress exposure was related to levels of interleukin‐6. CONCLUSIONS: Because dysregulated cortisol has been related to fatigue, poorer quality of life, and shorter survival in patients with ovarian cancer, those who have prior life events and chronic anxiety during the first year postdiagnosis may be at risk for more negative outcomes. Cancer 2018 . © 2018 American Cancer Society .
- Open Access
- 15 January 2018
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 4 (1) , e1
Internet-Based Group Intervention for Ovarian Cancer Survivors: Feasibility and Preliminary Results
Patient-Centered Innovations, Education and Technology for Cancer Care and Cancer Research
- 15 January 2018
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 4 (1) , e1
Open AccessInternet-Based Group Intervention for Ovarian Cancer Survivors: Feasibility and Preliminary Results
Patient-Centered Innovations, Education and Technology for Cancer Care and Cancer Research